Table 3. Pain conditions of different groups of patients by VAS scores and PCIA pressing times.
Variables | Time points | Parecoxib | Dexmedetomidine | Combined | Control |
---|---|---|---|---|---|
VAS | 4 h | 3.7±1.7c,d | 3.9±1.3c,d | 2.4±1.0a,b,d | 5.8±2.3a,b,c |
12 h | 2.9±0.9c,d | 3.0±1.2c,d | 1.8±0.4a,b,d | 4.6±1.7a,b,c | |
24 h | 1.9±0.2c,d | 2.1±0.6c,d | 1.4±0.1a,b,d | 2.8±0.8a,b,c | |
48 h | 1.1±0.1d | 1.0±0.1d | 1.1±0.1 d | 1.2±0.1a,b,c | |
PCIA | 48 h | 5.0±1.3c,d | 5.1±1.9c,d | 3.4±1.4a,b,d | 7.8±2.3a,b,c |
P<0.05, compared with the Parecoxib group;
P<0.05, compared with DEX group;
P<0.05, compared with Combined group;
P<0.05, compared with Control group.
VAS Visual Analogue Score, PICA patient-controlled intravenous analgesia pump.